VJOncology is committed to improving our service to you

ELCC 2018 | Increased survival in NSCLC: new considerations

VJOncology is committed to improving our service to you

Federico Cappuzzo

Speaking from the 2018 European Lung Cancer Congress (ELCC) in Geneva, Switzerland, Federico Cappuzzo, MD, PhD, of AUSL della Romagna, Ravenna, Italy, talks about how overall survival has improved in patients with non-small cell lung cancer (NSCLC) and the problems associated with this increase in survival.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter